StemCell Institute Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.stemcell.co.jp

Country

Japan

Exchange

Tokyo

Tokyo, JapanSubsidiary of Trim Medical Holdings Inc

StemCell Institute provides the stem cell banking business in Japan. The company is also involved in R&D of new cell-based treatments, and pharmaceuticals and medical devices, as well as cell contract management and transportation business.

Its portfolio also includes extraction, purification, processing, storage, testing and sales of biological tissue-derived components, and medical facility operation and management business. Incorporated in 1999, StemCell Institute is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.

Key Stats

52-Week Range

¥627.00¥1085.00

Beta0.59

Trailing P/E45.91

Forward P/E9.30

Trailing EPS15.42

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.